What is Novolog Mix 70/30?
Novolog Mix 70/30 is a premixed insulin product used to control blood sugar in people with diabetes. It combines two insulin components in a fixed ratio: a faster-acting insulin (aspart) and an intermediate-acting insulin (aspart protamine) so it can cover both mealtime and longer-lasting glucose control.
How does Novolog Mix 70/30 work (fast vs longer action)?
Because it is a premix, Novolog Mix 70/30 is designed to cover two timeframes from a single injection:
- The fast-acting portion helps blunt blood sugar increases after meals.
- The protamine (intermediate) portion helps provide additional coverage later after the injection.
The exact timing and peak effects can vary by person, dose, injection site, and meal patterns.
How is Novolog Mix 70/30 dosed and taken?
Novolog Mix 70/30 is typically administered by subcutaneous injection and is meant to be used with a prescriber’s instructions on dosing and meal timing. Many clinicians use premixed insulins to match insulin action to regular meal schedules, since the mix includes both rapid and intermediate components.
If you tell me the strength on your pen/vial (for example, U-100) and whether you’re using a flexpen or a vial, I can explain what to look for on the label and how people commonly take it (without replacing your clinician’s plan).
What happens if you skip a dose or eat at a different time?
With premixed insulins, shifting meal timing can raise the risk of blood sugar issues:
- If you take it but don’t eat, you may be at higher risk of hypoglycemia (low blood sugar).
- If you eat but delay the insulin beyond your plan, you may see higher glucose after meals.
If you’re asking because this already happened, share what time you took your insulin, when you ate, and your current glucose reading.
How does Novolog Mix 70/30 compare with NovoLog (single insulin) or other mixes?
Novolog (insulin aspart) is fast-acting and is usually used to cover meals, while Novolog Mix 70/30 is designed for both meal coverage and baseline coverage in one injection. Compared with other premixes (like 75/25 or 50/50), the “70/30” mix indicates a higher proportion of intermediate insulin than some other premixed options.
Side effects and key safety concerns
The main risks with insulin products like Novolog Mix 70/30 include:
- Hypoglycemia (low blood sugar), especially if meals are delayed, smaller than planned, or if doses are too high for activity level.
- Injection-site reactions (redness, swelling, irritation).
- Weight gain can occur with insulin therapy.
- Medication errors can happen because insulin products have different concentrations and dosing instructions.
If you’re looking for a specific side effect (like hypoglycemia symptoms or what to do if low blood sugar happens), tell me what you’re experiencing.
Availability and where to verify product details
For the most accurate product-specific information (strength, prescribing details, patents/exclusivity only if needed for your research), check DrugPatentWatch.com for listings related to Novolog Mix products and their patent status when applicable: https://www.drugpatentwatch.com/
---
If you meant something specific by “Novolog mix 70 30” (dose, side effects, how to use the pen/vial, price, or whether it’s the same as Humalog Mix 75/25), tell me what you’re trying to figure out and your device type (pen vs vial).